MedTrace Logo

Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction

NCT04900415 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-05-25

No results posted yet for this study

Summary

A combination of oral vitamin A (VitA) and intense aromatic chemosensory smell training (ST) by pulse aromatic stimulation will expedite the neurosensory recovery of olfaction in patients suffering from prolonged COVID-19-related olfactory dysfunction (OD).

Conditions

  • Coronavirus Disease 2019

Interventions

DRUG

Vitamin A

Metabolic supplement for neurogenesis at the olfactory apparatus

DEVICE

Electronic portable aromatic rehabilitation (EPAR) diffuser

Handheld essential oil ultrasonication diffuser technology

Sponsors & Collaborators

  • Pamela Youde Nethersole Eastern Hospital

    collaborator OTHER

  • Ivan FN Hung MD

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-22
Primary Completion
2021-03-12
Completion
2021-06-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04900415 on ClinicalTrials.gov